Irish firm Covidien has announced it intends to spin off its Hazelwood, Mo.-based pharmaceutical unit Mallinckrodt on June 28. The spinoff company will be called Mallinckrodt Pharmaceuticals.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan